- Home
- PMCB vs LIQT Comparison
PMCB vs LIQT Comparison
Compare PMCB & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- LIQT
- Stock Information
- Founded
- PMCB 1996
- LIQT 2004
- Country
- PMCB United States
- LIQT Denmark
- Employees
- PMCB N/A
- LIQT N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- LIQT Industrial Machinery/Components
- Sector
- PMCB Health Care
- LIQT Technology
- Exchange
- PMCB Nasdaq
- LIQT Nasdaq
- Market Cap
- PMCB 15.8M
- LIQT 15.8M
- IPO Year
- PMCB N/A
- LIQT N/A
- Fundamental
- Price
- PMCB $1.76
- LIQT $2.28
- Analyst Decision
- PMCB
- LIQT Strong Buy
- Analyst Count
- PMCB 0
- LIQT 2
- Target Price
- PMCB N/A
- LIQT $7.08
- AVG Volume (30 Days)
- PMCB 36.5K
- LIQT 8.6K
- Earning Date
- PMCB 09-17-2024
- LIQT 11-07-2024
- Dividend Yield
- PMCB N/A
- LIQT N/A
- EPS Growth
- PMCB N/A
- LIQT N/A
- EPS
- PMCB 0.54
- LIQT N/A
- Revenue
- PMCB N/A
- LIQT $17,720,520.00
- Revenue This Year
- PMCB N/A
- LIQT $5.96
- Revenue Next Year
- PMCB N/A
- LIQT $32.89
- P/E Ratio
- PMCB $3.31
- LIQT N/A
- Revenue Growth
- PMCB N/A
- LIQT 8.53
- 52 Week Low
- PMCB $1.39
- LIQT $1.90
- 52 Week High
- PMCB $2.58
- LIQT $4.10
- Technical
- Relative Strength Index (RSI)
- PMCB 48.48
- LIQT 36.02
- Support Level
- PMCB $1.72
- LIQT $2.85
- Resistance Level
- PMCB $1.95
- LIQT $3.10
- Average True Range (ATR)
- PMCB 0.26
- LIQT 0.18
- MACD
- PMCB -0.01
- LIQT -0.09
- Stochastic Oscillator
- PMCB 38.75
- LIQT 2.09
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.